Pieris Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

Note 5 - Accrued Expenses and Other Current Liabilities 3

9 Months Ended

12 Months Ended

Sep. 30, 2024

Dec. 31, 2023

5. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	September 30,		December 31,
	2024		2023
Professional fees	$	2,343	$	960
Compensation expense		1,462		175
Research and development expenses		418		120
Other		282		169
Total accrued expenses and other current liabilities	$	4,505	$	1,424

5. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):

	December 31,
	2023		2022
Professional fees	$	960	$	997
Compensation expense		175		762
Research and development expenses		120		683
Other		169		159
Total accrued expenses and other current liabilities	$	1,424	$	2,601